Practice patterns regarding prostate cancer and benign prostatic hyperplasia in Japanese primary care practitioners

International Journal of Urology

Volumn 14, Issue 5, 2007, Pages 412-415

  Fukagai, Takashi ^a   Maruyama, Kunitaka ^a   Nagata, Masakazu ^a   Morita, Masashi ^a   Naoe, Michio ^a   Yoshida, Hideki ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Digital rectal examination (DRE); Primary health care; Prostate specific antigen (PSA); Prostatic neoplasms

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANDROGEN; CERNITIN; CHLORMADINONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; EVIPROSTAT; HERBACEOUS AGENT; OXYBUTYNIN; PROPIVERINE; PROSTATE SPECIFIC ANTIGEN; TERAZOSIN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CHINESE HERB; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; HEALTH PRACTITIONER; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; INTERNATIONAL PROSTATE SYMPTOM SCORE; JAPANESE; MALE; MEDICAL PRACTICE; MULTIPLE CHOICE TEST; PATIENT REFERRAL; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; TREATMENT PLANNING; UROLOGY;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; JAPAN; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; QUESTIONNAIRES;

EID: 34248680763     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2007.01742.x     Document Type: Article

References (12)

1. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J. Clin. 2005 55 : 10 30.
2. Cancer registration committee of the Japanese Urological Association. Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association. Int. J. Urol. 2005 12 : 46 61.
3. Fukagai T, Morita M, Yoshida H. Cooperative care between urologists and general practitioners. Nippon Rinsho, 2002 60 : 459 64 (in Japanese).
4. Plawker MW, Fleisher JM, Nitti VW, Macchia RJ. Primary care practitioners: an analysis of their perceptions of voiding dysfunction and prostate cancer. J. Urol. 1996 155 : 601 4.
5. Fawzy A, Fontenot C, Guthrie R, Baudier MM. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer. Family Med. 1997 29 : 321 5.
6. Kim HL, Benson DA, Stern D, Gerber GS. Practice trends in the management of prostate disease by family practice physicians and general internists: an internet-based survey. Urology 2002 59 : 266 71.
7. Edlefsen KL, Mandelson MT, McIntosh MW, Andersen MR, Wagner EH, Urban N. Prostate-specific antigen for prostate cancer screening. Do physician characteristics affect its use? Am. J. Prev. Med. 1999 17 : 87 90.
8. Vastag B. Study concludes that moderate PSA levels are unrelated to prostate cancer outcomes. JAMA 2002 287 : 969 70.
9. American Urological Association (AUA). Prostate-specific antigen (PSA) best practice policy. Oncology (Williston Park) 2000 14 : 267 72.
10. Ferrini R, Woolf SH. American college of preventive medicine practice policy. Screening for prostate cancer in American men. Am. J. Prev. Med. 1998 15 : 81 4.
11. American College of Physicians. Screening for prostate cancer. Ann. Intern. Med. 1997 126 : 480 4.
12. Nakagawa S. Evaluation of mass screening for prostatic cancer. Nippon Rinsho 2002 60 (Suppl. 11 289 93. (in Japanese).